Connect with us

Technology

iRobot Reports Third-Quarter 2024 Financial Results

Published

on

Continues to Make Progress on “iRobot Elevate” Strategy

Revises Full-year 2024 Outlook

BEDFORD, Mass., Nov. 6, 2024 /PRNewswire/ — iRobot Corp. (NASDAQ: IRBT), a leader in consumer robots, today announced its financial results for the third quarter ended September 28, 2024.

“We continue to make progress on our turnaround strategy,” said Gary Cohen, iRobot’s CEO. “In the third quarter, we expanded our non-GAAP gross margin by 590 basis points year over year and improved our use of operating cash. However, our overall results did not meet the expectations we set in August, as persistent market segment and competitive headwinds impacted our sell-through performance. Although we now expect it will take more time to stabilize our revenue trend, we are on track to exceed our operating expense targets for the year, while at the same time continuing to invest in areas that are expected to drive growth.

“Our ongoing restructuring has fundamentally changed the way we innovate, develop and build our robots, which is central to improving our performance and generating long-term shareholder value. With the benefit of lower operating costs, we expect to enhance margins and improve profitability in 2025.

“As we move forward in this new chapter in iRobot’s history, one thing is abundantly clear: we have a powerful brand that will serve as the foundation for the turnaround of this Company. That brand power is at the heart of our turnaround strategy, iRobot Elevate. In executing that strategy, we are focused on providing our iconic brand with an improved platform to drive long-term profitable growth.”

Third-Quarter 2024 Financial Results (in millions, except per share amounts and percentages)

Q3 2024

Q3 2023

Revenue

$193.4

$186.2

GAAP Gross Margin

32.2 %

25.8 %

Non-GAAP Gross Margin

32.4 %

26.5 %

GAAP Operating Expenses

$55.1

$107.5

Non-GAAP Operating Expenses

$47.7

$90.1

GAAP Operating Income (Loss)

$7.3

($59.5)

Non-GAAP Operating Income (Loss)

$15.1

($40.6)

GAAP Net Loss Per Share

($0.21)

($2.86)

Non-GAAP Net Income (Loss) Per Share*

$0.03

($2.82)

*Beginning in the fourth quarter of fiscal 2023, the Company updated its calculation of non-GAAP financial measures to no longer exclude “IP litigation expense, net.” The metrics are presented in accordance with this updated methodology. As a result, the third quarter ended September 30, 2023 differs from those previously presented by the amount of IP litigation expense, net recorded in such period.

Additional Financial Highlights 

The Company increased non-GAAP gross margin in the third quarter by 590 basis points year over year as a result of its restructuring and iRobot Elevate initiatives.As of September 28, 2024, the Company’s cash and cash equivalents totaled $99.4 million, compared with $108.5 million as of the end of the second quarter of 2024. The Company also had an additional $41.1 million restricted cash set aside for future repayment of its term loan, subject to limited rights for inventory purchases, of which $40.0 million was drawn down at the close of the third quarter and received in the fourth quarter.As of September 28, 2024, the Company’s inventory totaled $149.2 million, compared with $244.5 million as of the end of the third quarter of 2023.During the third quarter, the Company sold 0.2 million shares under its at-the-market (ATM) offering program for total net proceeds of $1.4 million. At quarter end, the Company had $79.6 million remaining under its $100 million ATM offering program.As of September 28, 2024, iRobot had reduced its total headcount by 41% since year-end 2023.In the third quarter of 2024, revenue increased 23% in the U.S., declined 20% in Japan, and declined 11% in EMEA over the prior-year period. Excluding the unfavorable foreign currency impact, Japan revenue decreased 15% over the prior-year period.Revenue from mid-tier robots (with an MSRP between $300 and $499) and premium robots (with an MSRP of $500 or more) represented 79% of total robot sales in the third quarter of 2024, compared with 80% in the same period last year.

Marketing Highlights 

iRobot introduced the 2-in-1 Roomba Combo 2 Essential robot globally and Roomba Vac 2 Essential robot in North America. These robots are the first in the Company’s affordable Essential series that automatically empty their dustbins into the AutoEmpty dock after cleaning. The robots also provide twice the cleaning power of the original Essential series, include an enhanced bumper design to more seamlessly navigate floor space, and have the ability to recharge and resume during cleaning missions.In August, iRobot launched the Roomba Combo 10 Max in Japan, earning positive coverage in media outlets including Nikkei, NHK and Gizmodo.iRobot Roomba Combo Essential received the PCMag Editor’s Choice designation.iRobot products received favorable media coverage across the globe, including from CBS News, Engadget, The Verge, Tom’s Guide, ZDNet, The Ambient, and Europa Press.Roomba was a featured product in Amazon’s Prime Big Deal Days event in October. iRobot’s products received Prime Big Deal Day related media coverage in outlets including Good Morning America, NBC Select, The Sun, Frandroid and El Confidencial.

Fourth-Quarter and Full-Year 2024 Outlook

iRobot is providing GAAP and non-GAAP financial expectations for the fourth quarter ending December 28, 2024 and updating the full-year 2024 outlook it provided on August 7, 2024. A detailed reconciliation between the Company’s GAAP and non-GAAP expectations is included in the financial tables that appear at the end of this press release.

Fourth Quarter 2024:

Metric

GAAP

Adjustments

Non-GAAP

Revenue

$175 – $200 million

$175 – $200 million

Gross Margin

24% – 27%

~0%

24% – 27%

Operating Loss

($43) – ($34) million

~$12 million

($31) – ($22) million

Net Loss Per Share

($1.88) – ($1.58)

~$0.38

($1.50) – ($1.20)

Fiscal Year 2024:

Metric

GAAP

Adjustments

Non-GAAP

Revenue

$685 – $710 million

$685 – $710 million

Gross Margin

25% – 26%

~0%

25% – 26%

Operating Loss

($84) – ($75) million

~($20) million

($104) – ($95) million

Net Loss Per Share

($4.27) – ($3.96)

~($0.64)

($4.91) – ($4.60)

Third-Quarter 2024 Results Conference Call

On November 6, the Company will host a live conference call and webcast to review its financial results and discuss its outlook. The conference call details are as follows:

Date: Wednesday, November 6, 2024
Time: 8:30 a.m. ET
Call-In Number: 800-274-8461 (Alternate: 203-518-9814)
Conference ID: IRBTQ324

A live webcast of the conference call will be accessible on the event section of the Company’s website at https://investor.irobot.com/financial-information/quarterly-results. An archived version of the broadcast will be available on the same website shortly after the conclusion of the live event.

About iRobot Corp.
iRobot is a global consumer robot company that designs and builds thoughtful robots and intelligent home innovations that make life better. iRobot introduced the first Roomba robot vacuum in 2002. Today, iRobot is a global enterprise that has sold more than 50 million robots worldwide. iRobot’s product portfolio features technologies and advanced concepts in cleaning, mapping and navigation. Working from this portfolio, iRobot engineers are building robots and smart home devices to help consumers make their homes easier to maintain and healthier places to live. For more information about iRobot, please visit www.irobot.com

Cautionary Statement Regarding Forward-Looking Statements
This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which relate to, among other things: the Company’s expectations regarding future financial performance, including with respect to fourth quarter and fiscal year 2024 revenue, gross margin, operating (loss) income and net (loss) income per share, as well as fiscal year 2025 operating costs, margins and profitability; executing on the Company’s iRobot Elevate strategy; stabilization of revenue trends; and the Company’s business plans and strategies and the anticipated impact thereof. These forward-looking statements are based on the Company’s current expectations, estimates and projections about its business and industry, all of which are subject to change. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “could,” “seek,” “see,” “will,” “may,” “would,” “might,” “potentially,” “estimate,” “continue,” “expect,” “target,” similar expressions or the negatives of these words or other comparable terminology that convey uncertainty of future events or outcomes. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond our control, and are not guarantees of future results, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: (i) the Company’s ability to obtain capital when desired on favorable terms, if at all; (ii) the Company’s ability to realize the benefits of its operational restructuring; (iii) the impact of the COVID-19 pandemic and various global conflicts on the Company’s business and general economic conditions; (iv) the Company’s ability to implement its business strategy; (v) the risk that disruptions from the operational restructuring will harm the Company’s business, including current plans and operations; (vi) the ability of the Company to retain and hire key personnel, including successfully navigating its leadership transition; (vii) legislative, regulatory and economic developments affecting the Company’s business; (viii) general economic and market developments and conditions; (ix) the evolving legal, regulatory and tax regimes under which the Company operates; (x) potential business uncertainty, including changes to existing business relationships that could affect the Company’s financial performance; (xi) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities; (xii) current supply chain challenges including the Red Sea conflict; (xiii) the financial strength of our customers and retailers; (xiv) the impact of tariffs on goods imported into the United States; and (xv) competition, as well as the Company’s response to any of the aforementioned factors. Additional risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements are included under the caption “Risk Factors” in the Company’s most recent annual and quarterly reports filed with the SEC and any subsequent reports on Form 10-K, Form 10-Q or Form 8-K filed from time to time and available at www.sec.gov. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability and similar risks, any of which could have a material adverse effect on the Company’s financial condition, results of operations, or liquidity. The forward-looking statements included herein are made only as of the date hereof. The Company does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

 

iRobot Corporation

Consolidated Statements of Operations

(in thousands, except per share amounts)

(unaudited)

For the three months ended

For the nine months ended

September 28, 2024

September 30, 2023

September 28, 2024

September 30, 2023

Revenue

$               193,435

$               186,176

$               509,811

$               583,036

Cost of revenue:

Cost of product revenue

131,058

137,888

383,865

443,932

Amortization of acquired intangible assets

292

864

Total cost of revenue

131,058

138,180

383,865

444,796

Gross profit

62,377

47,996

125,946

138,240

Operating expenses:

Research and development

19,630

37,336

76,739

116,576

Selling and marketing

29,270

41,558

98,966

139,630

General and administrative

3,232

28,270

(33,552)

85,116

Restructuring and other

1,922

152

24,298

8,236

Amortization of acquired intangible assets

1,066

174

1,405

529

Total operating expenses

55,120

107,490

167,856

350,087

Operating income (loss)

7,257

(59,494)

(41,910)

(211,847)

Other expense, net

(12,548)

(19,113)

(24,583)

(24,217)

Loss before income taxes

(5,291)

(78,607)

(66,493)

(236,064)

Income tax expense

1,080

598

1,917

5,053

Net loss

$                  (6,371)

$                (79,205)

$                (68,410)

$              (241,117)

Net loss per share:

Basic

$                    (0.21)

$                    (2.86)

$                    (2.34)

$                    (8.73)

Diluted

$                    (0.21)

$                    (2.86)

$                    (2.34)

$                    (8.73)

Number of shares used in per share calculations:

Basic

30,348

27,738

29,276

27,608

Diluted

30,348

27,738

29,276

27,608

Stock-based compensation included in above figures:

Cost of revenue

$                      387

$                      838

$                   1,486

$                   2,226

Research and development

1,296

3,355

4,994

8,737

Selling and marketing

903

1,384

3,403

4,221

General and administrative

2,894

3,798

8,054

10,696

Total

$                   5,480

$                   9,375

$                 17,937

$                 25,880

 

 iRobot Corporation

 Condensed Consolidated Balance Sheets

 (unaudited, in thousands)

September 28, 2024

December 30, 2023

 Assets

 Cash and cash equivalents

$                       99,447

$                   185,121

 Restricted cash

41,082

 Accounts receivable, net

101,326

79,387

 Inventory

149,156

152,469

 Other current assets

32,774

48,513

Total current assets

423,785

465,490

 Property and equipment, net

25,405

40,395

 Operating lease right-of-use assets

15,137

19,642

 Deferred tax assets

9,093

8,512

 Goodwill

175,928

175,105

 Intangible assets, net

3,635

5,044

 Other assets

16,932

19,510

Total assets

$                     669,915

$                   733,698

 Liabilities and stockholders’ equity

 Accounts payable

$                     195,133

$                   178,318

 Accrued expenses

88,384

97,999

 Deferred revenue and customer advances

9,121

10,830

Total current liabilities

292,638

287,147

 Term loan

186,713

201,501

 Operating lease liabilities

22,892

27,609

 Other long-term liabilities

17,510

20,954

Total long-term liabilities

227,115

250,064

Total liabilities

519,753

537,211

 Stockholders’ equity

150,162

196,487

Total liabilities and stockholders’ equity

$                     669,915

$                   733,698

 

 iRobot Corporation

Consolidated Statements of Cash Flows

 (unaudited, in thousands)

For the nine months ended

September 28, 2024

September 30, 2023

Cash flows from operating activities:

Net loss

$                (68,410)

$              (241,117)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

16,912

21,367

Loss on equity investment

375

3,910

Stock-based compensation

17,937

25,880

Provision for inventory excess and obsolescence

11,800

1,740

Change in fair value of term loan

13,515

5,292

Debt issuance costs expensed under fair value option

529

11,837

Deferred income taxes, net

(651)

4,115

Other

(6,318)

(8,618)

Changes in operating assets and liabilities — (use) source

Accounts receivable

(22,073)

(7,943)

Inventory

(10,539)

32,935

Other assets

15,598

12,544

Accounts payable 

16,674

28,904

Accrued expenses and other liabilities

(15,825)

(4,483)

Net cash used in operating activities

(30,476)

(113,637)

Cash flows from investing activities:

Additions of property and equipment

(118)

(3,132)

Purchase of investments

(56)

(213)

Net cash used in investing activities

(174)

(3,345)

Cash flows from financing activities:

Proceeds from employee stock plans

9

Income tax withholding payment associated with restricted stock vesting

(491)

(1,924)

Proceeds from issuance of common stock, net of issuance costs

19,359

Repayment of term loan

(34,947)

Proceeds from term loan

200,000

Payment of debt issuance costs

(529)

(11,837)

Net cash (used in) provided by financing activities

(16,608)

186,248

Effect of exchange rate changes on cash, cash equivalents and restricted cash

1,251

4,193

Net (decrease) increase in cash, cash equivalents and restricted cash

(46,007)

73,459

Cash, cash equivalents and restricted cash, at beginning of period

187,887

117,949

Cash, cash equivalents and restricted cash, at end of period

$               141,880

$               191,408

Cash, cash equivalents and restricted cash, at end of period:

Cash and cash equivalents

$                 99,447

$               189,649

Restricted cash

41,082

Restricted cash, non-current (included in other assets)

1,351

1,759

Cash, cash equivalents and restricted cash, at end of period

$               141,880

$               191,408

 

 iRobot Corporation

Supplemental Information

(unaudited)

For the three months ended

For the nine months ended

September 28, 2024

September 30, 2023

September 28, 2024

September 30, 2023

Revenue by Geography: *

    Domestic

$               105,137

$                 85,781

$               258,398

$               288,725

    International

88,298

100,395

251,413

294,311

Total

$               193,435

$               186,176

$               509,811

$               583,036

Robot Units Shipped *

    Solo and other

287

446

854

1,492

    2-in-1

445

181

908

403

Total

732

627

1,762

1,895

Revenue by Product Category **

    Solo and other

$                        83

$                      126

$                      268

$                      449

    2-in-1

110

60

242

134

Total

$                      193

$                      186

$                      510

$                      583

Average gross selling prices for robot units

$                      313

$                      331

$                      329

$                      354

Headcount

661

1,126

* in thousands

** in millions

Certain numbers may not total due to rounding

 

iRobot Corporation
Explanation of Non-GAAP Measures

In addition to disclosing financial results in accordance with U.S. GAAP, this earnings release contains references to the non-GAAP financial measures described below. We use non-GAAP measures to internally evaluate and analyze financial results. We believe these non-GAAP financial measures provide investors with useful supplemental information about the financial performance of our business, enable comparison of financial results between periods where certain items may vary independent of business performance, and enable comparison of our financial results with other public companies, many of which present similar non-GAAP financial measures.

Our non-GAAP financial measures reflect adjustments based on the following items. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations from these results should be carefully evaluated.

Amortization of acquired intangible assets: Amortization of acquired intangible assets consists of amortization of intangible assets including completed technology, customer relationships, and reacquired distribution rights acquired in connection with business combinations as well as any non-cash impairment charges associated with intangible assets in connection with our past acquisitions. Amortization charges for our acquisition-related intangible assets are inconsistent in size and are significantly impacted by the timing and valuation of our acquisitions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance.

Net Merger, Acquisition and Divestiture (Income) Expense: Net merger, acquisition and divestiture (income) expense primarily consists of transaction fees, professional fees, and transition and integration costs directly associated with mergers, acquisitions and divestitures, including with respect to the iRobot-Amazon Merger. It also includes business combination adjustments including adjustments after the measurement period has ended. During the first quarter of fiscal 2024, the adjustment included the one-time net termination fee received as a result of the termination of the iRobot-Amazon Merger. The occurrence and amount of these costs will vary depending on the timing and size of these transactions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance.

Stock-Based Compensation: Stock-based compensation is a non-cash charge relating to stock-based awards. We exclude this expense as it is a non-cash expense, and we assess our internal operations excluding this expense and believe it facilitates comparisons to the performance of other companies.

Restructuring and Other: Restructuring charges are related to one-time actions associated with realigning resources, enhancing operational productivity and efficiency, or improving our cost structure in support of our strategy. Such actions are not reflective of ongoing operations and include costs primarily associated with severance and related costs, charges related to paused work unrelated to our core business, costs associated with the Chief Executive Officer transition and other non-recurring costs directly associated with resource realignments tied to strategic initiatives or changes in business conditions. We exclude these items from our non-GAAP measures when evaluating our recent and prospective business performance as such items vary significantly based on the magnitude of the action and do not reflect anticipated future operating costs. In addition, these charges do not necessarily provide meaningful insight into the fundamentals of current or past operations of our business.

Gain/Loss on Strategic Investments: Gain/loss on strategic investments includes fair value adjustments, realized gains and losses on the sales of these investments and losses on the impairment of these investments. We exclude these items from our non-GAAP measures because we do not believe they correlate to the performance of our core business and may vary in size based on market conditions and events. We believe that the exclusion of these gains or losses provides investors with a supplemental view of our operational performance.

Debt issuance costs: Debt issuance costs include various incremental fees and commissions paid to third parties in connection with the issuance of debt. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance.

Income tax adjustments: Income tax adjustments include the tax effect of the non-GAAP adjustments, calculated using the appropriate statutory tax rate for each adjustment. We regularly assess the need to record valuation allowances based on the non-GAAP profitability and other factors. We also exclude certain tax items, including the impact from stock-based compensation windfalls/shortfalls, which are not reflective of income tax expense incurred as a result of current period earnings. We believe disclosure of the income tax provision before the effect of such tax items is important to permit investors’ consistent earnings comparison between periods.

iRobot Corporation

Supplemental Reconciliation of GAAP Actuals to Non-GAAP Actuals

(in thousands, except per share amounts)

(unaudited)

For the three months ended

For the nine months ended

September 28, 2024

September 30, 2023

September 28, 2024

September 30, 2023

 GAAP Revenue

$               193,435

$               186,176

$               509,811

$               583,036

 GAAP Gross Profit

$                 62,377

$                 47,996

$               125,946

$               138,240

Amortization of acquired intangible assets

292

864

Stock-based compensation

387

838

1,486

2,226

Net merger, acquisition and divestiture expense

288

898

 Non-GAAP Gross Profit

$                 62,764

$                 49,414

$               127,432

$               142,228

 GAAP Gross Margin

32.2 %

25.8 %

24.7 %

23.7 %

 Non-GAAP Gross Margin

32.4 %

26.5 %

25.0 %

24.4 %

 GAAP Operating Expenses

$                 55,120

$               107,490

$               167,856

$               350,087

Amortization of acquired intangible assets

(1,066)

(174)

(1,405)

(529)

Stock-based compensation 

(5,093)

(8,537)

(16,451)

(23,654)

Net merger, acquisition and divestiture income (expense)

656

(8,564)

74,813

(21,991)

Restructuring and other

(1,922)

(152)

(24,298)

(8,236)

 Non-GAAP Operating Expenses*

$                 47,695

$                 90,063

$               200,515

$               295,677

 GAAP Operating Expenses as a % of GAAP Revenue

28.5 %

57.7 %

32.9 %

60.0 %

 Non-GAAP Operating Expenses as a % of Non-GAAP Revenue*

24.7 %

48.4 %

39.3 %

50.7 %

 GAAP Operating Income (Loss)

$                   7,257

$                (59,494)

$                (41,910)

$              (211,847)

Amortization of acquired intangible assets

1,066

466

1,405

1,393

Stock-based compensation

5,480

9,375

17,937

25,880

Net merger, acquisition and divestiture (income) expense

(656)

8,852

(74,813)

22,889

Restructuring and other

1,922

152

24,298

8,236

 Non-GAAP Operating Income (Loss)*

$                 15,069

$                (40,649)

$                (73,083)

$              (153,449)

 GAAP Operating Margin

3.8 %

(32.0) %

(8.2) %

(36.3) %

 Non-GAAP Operating Margin*

7.8 %

(21.8) %

(14.3) %

(26.3) %

iRobot Corporation

Supplemental Reconciliation of GAAP Actuals to Non-GAAP Actuals continued

(in thousands, except per share amounts)

(unaudited)

For the three months ended

For the nine months ended

September 28, 2024

September 30, 2023

September 28, 2024

September 30, 2023

 GAAP Income Tax Expense

$                   1,080

$                      598

$                   1,917

$                   5,053

Tax effect of non-GAAP adjustments

650

32,045

1,667

565

Other tax adjustments

(203)

(1,638)

(811)

(4,150)

 Non-GAAP Income Tax Expense

$                   1,527

$                 31,005

$                   2,773

$                   1,468

 GAAP Net Loss

$                  (6,371)

$                (79,205)

$                (68,410)

$              (241,117)

Amortization of acquired intangible assets

1,066

466

1,405

1,393

Stock-based compensation

5,480

9,375

17,937

25,880

Net merger, acquisition and divestiture (income) expense

(656)

8,852

(74,813)

22,889

Restructuring and other

1,922

152

24,298

8,236

Loss on strategic investments

758

375

3,910

Debt issuance costs

52

11,837

529

11,837

Income tax effect

(447)

(30,407)

(856)

3,585

 Non-GAAP Net Income (Loss)*

$                   1,046

$                (78,172)

$                (99,535)

$              (163,387)

 GAAP Net Loss Per Diluted Share

$                    (0.21)

$                    (2.86)

$                    (2.34)

$                    (8.73)

Amortization of acquired intangible assets

0.03

0.02

0.05

0.05

Stock-based compensation

0.18

0.34

0.61

0.93

Net merger, acquisition and divestiture (income) expense

(0.02)

0.32

(2.55)

0.83

Restructuring and other

0.06

0.83

0.30

Loss on strategic investments

0.03

0.01

0.14

Debt issuance costs

0.43

0.02

0.43

Income tax effect

(0.01)

(1.10)

(0.03)

0.13

 Non-GAAP Net Income (Loss) Per Diluted Share*

$                     0.03

$                    (2.82)

$                    (3.40)

$                    (5.92)

Number of shares used in diluted per share calculation

30,551

27,738

29,276

27,608

Supplemental Information

Days sales outstanding

48

36

GAAP Days in inventory

104

161

Non-GAAP Days in inventory(1)

104

163

* Beginning in the fourth quarter of fiscal 2023, we updated our calculation of non-GAAP financial measures to no longer exclude “IP litigation expense, net.” The metrics for each period are presented in accordance with this updated methodology; as a result, the third quarter and the nine months ended September 30, 2023 differ from those previously presented by the amount of IP litigation expense, net recorded in such period.

(1) Non-GAAP Days in inventory is calculated as inventory divided by (Revenue minus Non-GAAP Gross Profit), multiplied by 91 days.

 

 iRobot Corporation

Supplemental Reconciliation of Fourth Quarter and Full Year 2024 GAAP to Non-GAAP Guidance

(unaudited)

Q4-24

FY-24

GAAP Gross Profit

$42 – $54 million

$168 – $179 million

Stock-based compensation

~$0 million

~$2 million

Total adjustments

~$0 million

~$2 million

Non-GAAP Gross Profit

$42 – $54 million

$170 – $181 million

Q4-24

FY-24

GAAP Gross Margin

24% – 27%

25% – 26%

Stock-based compensation

~0%

~0%

Total adjustments

~0%

~0%

Non-GAAP Gross Margin

24% – 27%

25% – 26%

Q4-24

FY-24

GAAP Operating Expenses

$85 – $86 million

$252 – $254 million

Amortization of acquired intangible assets

~($0) million

~($2) million

Stock-based compensation

~($6) million

~($23) million

Net merger, acquisition and divestiture income (expense)

~$75 million

Restructuring and other

~($5) million

~($29) million

Total adjustments

~($11) million

~$22 million

Non-GAAP Operating Expenses

$74 – $75 million

$274 – $276 million

Q4-24

FY-24

GAAP Operating Loss

($43) – ($34) million

($84) – ($75) million

Amortization of acquired intangible assets

~$0 million

~$2 million

Stock-based compensation

~$7 million

~$25 million

Net merger, acquisition and divestiture expense (income)

~($75) million

Restructuring and other

~$5 million

~$29 million

Total adjustments

~$12 million

~($20) million

Non-GAAP Operating Loss

($31) – ($22) million

($104) – ($95) million

Q4-24

FY-24

GAAP Net Loss Per Share

($1.88) – ($1.58)

($4.27) – ($3.96)

Amortization of acquired intangible assets

~$0.01

~$0.05

Stock-based compensation

~$0.22

~$0.83

Net merger, acquisition and divestiture expense (income)

~($2.53)

Restructuring and other

~$0.15

~$0.98

Loss on strategic investments

~$0.01

Debt issuance costs

~$0.02

Income tax effect

~$0

~$0

Total adjustments

~$0.38

~($0.64)

Non-GAAP Net Loss Per Share

($1.50) – ($1.20)

($4.91) – ($4.60)

Number of shares used in per share calculations*

~30.6 million

~29.6 million

* Number of shares does not include any additional issuances under our ATM

Certain numbers may not total due to rounding

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/irobot-reports-third-quarter-2024-financial-results-302297065.html

SOURCE iRobot Corporation

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Wistron Celebrates Grand Opening of First U.S. Smart Factory Marking Milestone in Global Smart Manufacturing Strategy

Published

on

By

FORT WORTH, Texas, July 21, 2026 /PRNewswire/ — Wistron Corporation (“Wistron”) celebrated the grand opening of its D1 AI smart facility in Fort Worth, Texas, the site where the first NVIDIA GB300 Grace Blackwell Ultra Superchip was built and mass-produced in the United States. The US$ 700 million facility, spanning approximately 324,000 square foot, was officially unveiled during a ceremony led by Wistron Chairman Simon Lin and NVIDIA Founder and CEO Jensen Huang. Jessica Rogers, Director of the Economic Development Department for the City of Fort Worth, and Alexander Tah-ray Yui, Taiwan’s Representative to the United States, were among the government officials and business leaders who attended, marking a milestone in the expansion of Wistron’s global footprint and advanced manufacturing capabilities.

This is a key hub in Wistron’s global AI infrastructure manufacturing network. The facility runs on NVIDIA accelerated computing and integrates NVIDIA’s Nemotron and Cosmos open frontier models and Omniverse and Metropolis libraries, using digital twin technology to optimize factory design, production workflows, and operational efficiency. It is Wistron’s first U.S.-based manufacturing facility, established to serve customers locally and produce NVIDIA’s most advanced and cutting-edge products. Wistron Chairman Simon Lin said “The operation here is not typical manufacturing. It is new, very comprehensive, and high-tech. Right now we produce the NVIDIA GB300 Grace Blackwell Ultra Superchip, and beyond, we are also going to produce the NVIDIA Vera Rubin Superchip here. In the next couple of years, this location will be one of the most important, as we build AI infrastructure here in the United States. I think this is the reason we say that there will be the next chapter, and we are going to empower AI from Texas.”

Responding to Customer Needs: Texas, the Newest Global Manufacturing Hub
At this pivotal moment for global AI infrastructure, Wistron is drawing on decades of global manufacturing experience to expand its footprint in Texas, a state with a well-established ecosystem for logistics, talent recruitment, and advanced manufacturing. The new D1 facility produces the NVIDIA GB300 Grace Blackwell Ultra Superchip and soon, the NVIDIA Vera Rubin Superchip — critical to powering the next generation of AI computing. The new Fort Worth facility strengthens a critical upstream layer of the AI infrastructure supply chain by expanding domestic capacity to assemble and test NVIDIA AI systems. These servers can be integrated into NVIDIA DSX infrastructure, with DSX providing the common architecture and technologies needed to deploy and operate energy-efficient AI factories at scale.

One-Stop Operational Ecosystem Strengthens U.S. AI Supply Chain Resilience
Behind every breakthrough in AI computing lies the manufacturing capability to scale it. Wistron is expanding its AI server production capabilities from Taiwan to the United States, guided by a vision of precision, efficiency, and sustainability. This reflects a broader industry shift: AI leadership is determined not only by technological breakthroughs, but also by the operational capability to transform innovation into high-volume production with consistent quality, supply chain resilience, and predictable delivery. By establishing AI infrastructure manufacturing capacity in the United States, Wistron is building a one-stop operational ecosystem spanning manufacturing and after-sales service — shortening delivery timelines and customer support cycles, strengthening supply chain resilience, and laying the foundation for long-term competitive advantage as AI infrastructure continues to scale.

Partnering with NVIDIA to Pioneer a New Model for Smart Manufacturing and Energy Optimization
As the era of physical AI begins, Wistron is extending its smart manufacturing capabilities to the United States, creating a new model for AI infrastructure production built on digital manufacturing, energy optimization, and local operations. Jensen Huang said: “The largest infrastructure buildout in history is underway. Demand for AI factories—the engine of this next industrial revolution—is incredible, and they must be produced everywhere. Together, NVIDIA and Wistron are restoring US advanced manufacturing capacity in Texas, creating skilled jobs and strengthening America’s AI supply chain.” As demand for advanced manufacturing grows in Texas, smarter planning of production loads and energy use will give the plant greater control and flexibility over its electricity needs.

Turning Global Experience into Scalable AI Infrastructure
Simon Lin stressed that the speed the AI era demands comes with its own responsibility. “In the AI era, the pressure of speed is also a form of responsibility,” Lin said. “We don’t just need to build fast; we need to build right.”

The Fort Worth plant will serve as the core engine of Wistron’s U.S. manufacturing operations, the company said, connecting its global production network with ecosystem partners as it scales advanced AI manufacturing. Wistron said that the investment reflects efforts to deepen its technical capabilities, strengthen the resilience and efficiency of global supply chains, and support the next phase of AI infrastructure development.

About Wistron:
Wistron Corporation is a leading global technology service provider delivering advanced ICT products, AI infrastructure, and manufacturing solutions to technology brands worldwide. With more than 63,000 employees across North America, Europe, and Asia, Wistron continues to expand its AI, cloud, and advanced manufacturing capabilities to support the next generation of intelligent computing. For more information about Wistron, please visit the official website at www.wistron.com. Additional information about the event is available on the event website.

Media Contact:
Joyce WL Chou
joyce_wl_chou@wistron.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/wistron-celebrates-grand-opening-of-first-us-smart-factory-marking-milestone-in-global-smart-manufacturing-strategy-302831439.html

SOURCE Wistron Corporation

Continue Reading

Technology

NSG Bio Accelerates Breakthrough Biotech Innovation in Singapore

Published

on

By

New initiative under NSG Bio Tomorrow will support promising startups developing next-generation approaches in respiratory and neonatal care

SINGAPORE, July 22, 2026 /PRNewswire/ — The NSG Bio Tomorrow initiative aims at supporting emerging life sciences startups working on complex challenges in respiratory and neonatal care.

Launched through the support of Chiesi Group, The Impulse initiative will provide a selected startup with one year of NSG Bio membership and access to a dedicated laboratory bench at NSG Bio Singapore. The initiative is designed to help early-stage biotech companies move from promising science toward stronger proof-of-concept work in a fully equipped research environment.

The initiative comes at a time when the biotech industry is increasingly looking for faster, more connected ways to move high-potential science from the lab toward real-world patient impact. For startups, access to infrastructure is only one part of the challenge. Equally important are the right networks, industry visibility, technical environment, and opportunities to engage with partners who understand the path from early discovery to clinical relevance.

The programme will focus on startups developing innovative biotechnological solutions with potential relevance to chronic respiratory diseases and neonatal conditions. Areas of interest include cell therapies, gene therapies, gene-editing technologies, regenerative tissue engineering, engineered or programmable living systems, lung-targeted delivery platforms, preventive approaches, and small-molecule-based approaches.

The selected startup will gain access to NSG Bio’s laboratory infrastructure, shared workspaces, meeting facilities, and wider community of biotech entrepreneurs, researchers, scientific leaders, and industry partners. The support is intended to help the company advance key research milestones while becoming part of Singapore’s growing life-science innovation ecosystem.

For NSG Bio, the initiative is part of NSG Bio Tomorrow, its ecosystem-building arm created to expand the company’s role beyond facilities and real estate. While NSG Bio is known for providing high-quality laboratory and office infrastructure for biotech companies, NSG Bio Tomorrow focuses on building the programmes, partnerships, and opportunities that help startups grow.

“Biotech companies need more than lab space. They need access, momentum, and the right ecosystem around them,” said Hasyim Sim, Co-Founder and Chief Operating Officer, NSG Bio. “Through NSG Bio Tomorrow, we are building initiatives that help promising startups connect with partners, unlock opportunities, and move their science forward. This initiative reflects exactly the kind of role we want to play in the biotech ecosystem.”

“Chiesi is committed to supporting innovation that can make a meaningful difference for patients, and we work with entrepreneurs, researchers and partners to advance meaningful ideas,” said Fabrizio Conicella, Vice President, Center of Open Innovation & Competence at Chiesi Group. “By supporting this NSG Bio Tomorrow initiative, we want to create an opportunity for early-stage innovators to access the infrastructure and ecosystem support needed to develop impactful science in respiratory and neonatal care.”

NSG Bio Tomorrow programme also reinforces Singapore’s position as a growing hub for biotech innovation in Asia, where startups, research institutions, investors, and industry partners are increasingly coming together to support the next generation of healthcare companies.

Applications open on 22 July 2026 at 09:00 a.m. SGT. Finalists will be invited to present at a virtual pitch event, after which the selected startup will be announced.

About NSG Bio

NSG Bio is Singapore’s leading provider of BSL-2 certified co-working laboratory and office spaces, supporting life-science companies from early research through growth. Through its facilities, community, and ecosystem initiatives, NSG Bio enables biotech innovators to accelerate research, access networks, and build companies that address critical healthcare challenges.

About NSG Bio Tomorrow

NSG Bio Tomorrow is NSG Bio’s ecosystem-building arm, created to support the next generation of biotech innovation through partnerships, programmes, community initiatives, and opportunities that extend beyond physical laboratory infrastructure. Its mission is to strengthen the biotech industry by connecting startups with the resources, expertise, and networks they need to thrive.

About Chiesi Group 

Chiesi is a research-oriented international biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. As a certified B Corp since 2019, Chiesi is part of a global community of businesses that meet high standards of social and environmental impact. 

With 90 years of experience, Chiesi is headquartered in Parma (Italy), with 31 affiliates worldwide, and counts more than 7,900 employees. The Group’s research and development centre in Parma works alongside 6 other important R&D hubs in France, the US, Canada, China, the UK, and Sweden. For further information please visit https://www.chiesi.com/en/home 

Media Contact
Giridharan
Laboratory Manager
NSG Bio
giridharan@nsgbio.com
87797175

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/nsg-bio-accelerates-breakthrough-biotech-innovation-in-singapore-302830494.html

SOURCE NSG Bio

Continue Reading

Technology

House Judiciary Committee Passes Bill that Would Prevent Future Immigration Crises: Swift Action Needed by Full House, Says FAIR

Published

on

By

WASHINGTON, July 21, 2026 /PRNewswire/ — Today, the House Judiciary Committee passed an updated version of H.R. 2, the landmark border security bill from last congressional session. The bill now awaits consideration by the full House of Representatives. The Federation for American Immigration Reform (FAIR) urges Speaker Mike Johnson to schedule a final floor vote as soon as possible.

The Secure Border Act systematically closes the loopholes that allowed the Biden administration to unleash the largest and most damaging wave of illegal immigration in American history. Enactment of this legislation would prevent future anti-borders administrations from shirking their responsibilities to secure our borders and enforce our immigration laws; asserting unlimited discretion to parole inadmissible aliens to enter the country; or releasing millions of illegal aliens into the country, rather than detaining them or returning them to the country from which they entered.

“We congratulate the Judiciary Committee for its swift action on this critical legislation,” said Dale Wilcox, executive director and general counsel of FAIR. “Ending border chaos and rampant illegal immigration was a key reason that Republicans regained control of the White House and both chambers of Congress in the last election. The clock is ticking on the 119th Congress, and Republicans only have a short time to deliver on the promises they made to voters in 2024, before the midterms.

“Right now, our immigration laws are being enforced in the interests of the American people. As the last administration demonstrated, enforcement of those laws is not guaranteed unless Congress acts to prevent similar abuse in the future. Now is the time for decisive action in the House, where this bill can be passed with a simple majority vote, and an opportunity for Senate Majority Leader John Thune to put every member of that body on record before voters go to the polls in the fall,” Wilcox concluded.

Hayley Hill, hhill@fairus.org 202-328-7004

View original content to download multimedia:https://www.prnewswire.com/news-releases/house-judiciary-committee-passes-bill-that-would-prevent-future-immigration-crises-swift-action-needed-by-full-house-says-fair-302831443.html

SOURCE Federation for American Immigration Reform (FAIR)

Continue Reading

Trending